Obicetrapib

Obicetrapib is a CETP inhibitor that is intended to treat dyslipidemia.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Obicetrapib is a CETP inhibitor that is intended to treat dyslipidemia. Obicetrapib is a lipid-modifying agent that blocks a blood protein called CETP, thereby lowering the level of LDL cholesterol. The most common side effects include hypertension, dizziness, headache, diarrhea, and abdominal pain.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1377022457 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.